Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy

scientific article

Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID16047643

P2093author name stringYang Y
Shimizu M
Ohta K
Koizumi S
Kasahara Y
Yachie A
Nakai A
P433issue1
P304page(s)35-40
P577publication date2005-07-01
P1433published inClinical NephrologyQ15763520
P1476titleTreatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy
P478volume64

Reverse relations

cites work (P2860)
Q80112924Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors
Q37152477Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study
Q35528122Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients
Q87393387Chapter 10: Immunoglobulin A nephropathy
Q35819489Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial
Q34891823Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial
Q33516579Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents
Q84978295Evidence-based practice guideline for the treatment of CKD
Q36739672Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy
Q36407313Hypertension in children with chronic kidney disease: pathophysiology and management
Q57040510Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study)
Q34169794Risk factors for progression of chronic kidney disease
Q35614311Therapeutic approach to FSGS in children

Search more.